PATENT CLAIM ANALYSIS

Application Number: 15773524
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-01
Patent Classification: ["424", "234100"]

Abstract:
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.

Claim (Index 5):
The recombinant virulence attenuated Gram-negative bacterial strain for use according to  claim 1 , wherein the recombinant virulence attenuated Gram-negative bacterial strain is a mutant  Yersinia  strain in which all the effector-encoding genes which encode bacterial effector proteins which are virulent toward eukaryotic cells are mutated such that the resulting  Yersinia  no longer produce any functional bacterial effector proteins which are virulent toward eukaryotic cells.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 93.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15039116', '13364437', '10818071', '15565609', '09763620']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7161644878507005
- 35 USC 102 Novelty (BERT): 0.5214546333980569
- Combined Prediction Score: 0.6966935024054361
- Mean Citation Score: 279.251184
- Max Citation Score: 299.61252
- Similarity Product: 218.7147523027468

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test